Patent details
EP3717455 Title: PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
Basic Information
- Publication number:
- EP3717455
- PCT Application Number:
- US2018063451
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP188164685
- PCT Publication Number:
- WO2019109021
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- French Title of Invention:
- PROCÉDÉS POUR PRÉPARER DES MODULATEURS DE RÉGULATEUR DE CONDUCTANCE TRANSMEMBRANAIRE DE MUCOVISCIDOSE
- German Title of Invention:
- VERFAHREN ZUR HERSTELLUNG VON CFTR-REGULATOREN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 11/12/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 20/12/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 20/11/2024
- Unitary Effect Registration Date:
- 20/12/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 30/11/2018
- Grant date:
- 20/11/2024
- EP Publication Date:
- 07/10/2020
- PCT Publication Date:
- 06/06/2019
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 20/11/2024
- EP B1 Publication Date:
- 20/11/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 30/11/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 13/11/2024
- Name:
- Vertex Pharmaceuticals Incorporated
- Address:
- 50 Northern Avenue, Boston, MA 02210, United States (US)
Inventor
1
- Name:
- SOLSONA ROCABERT, Juan, Gabriel
- Address:
- Spain (ES)
2
- Name:
- MORGAN, Adam
- Address:
- United States (US)
3
- Name:
- LEMERCIER LEWANDOWSKI, Berenice
- Address:
- United States (US)
4
- Name:
- ROEPER, Stefanie
- Address:
- United States (US)
5
- Name:
- LEWIS, Robert
- Address:
- United States (US)
6
- Name:
- RYAN, Michael
- Address:
- United States (US)
7
- Name:
- LOOKER, Adam
- Address:
- United States (US)
8
- Name:
- WILDE, Nathan
- Address:
- United States (US)
Priority
- Priority Number:
- 17382829
- Priority Date:
- 01/12/2017
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- C07D 215/56; C07C 69/96; C07B 59/00; C07C 33/18;
Publication
European Patent Bulletin
1
- Issue number:
- 202447
- Publication date:
- 20/11/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202451
- Publication date:
- 18/12/2024
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
3
- Issue number:
- 202503
- Publication date:
- 15/01/2025
- Description:
- Unitary Effect Request Receipt
4
- Issue number:
- 202504
- Publication date:
- 22/01/2025
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|